Table 3.
Key media components influencing charge Heterogeneitya.
| Components | Cell line | Rangeb | Effectsc |
Ref. | |
|---|---|---|---|---|---|
| Acidic | Basic | ||||
| Glucose (g/L) | CHO-K1 | 2 → 15 | Increases | N/A | Sissolak et al.36 |
| CHO | 11.5–23 | Increases | N/A | Quan et al.67 | |
| Copper (mM) | CHO-DG44 | 0.004, 0.04, 0.15, 0.4 | N/A | Increases | Weng et al.21 |
| CHO-GS | 0 → 0.0315 | Decreases | N/A | Gangwar et al.22 | |
| CHO-DXB11 | 0, 0.00015, 0.00025, 0.0005, 0.001, 0.002, 0.003 | Decreases | Increases | Yuk et al.43 | |
| CHO | 1X → 4X | N/A | Increases | Luo et al.42 | |
| CHO-K1 | 0.0004, 0.00055, 0.00075, 0.001 | Affected | Increases | Kaschak et al.40 | |
| CHO-S | 0x, 1x, 3x | Affected | N/A | Rouiller et al.52 | |
| CHO-K1 | 0, 0.005, 0.05, 0.1 | Decreases | N/A | Chaderjian et al.66 | |
| CHOK1SV | N/A (increased) | Decreases | Decreases | Hazeltine et al.46 | |
| Iron (mM) | CHO-GS | 0.0197, 0.3008, 0.3581, 1.6240 | Increases | N/A | Gangwar et al.22 |
| CHO/dhFr | 0.01, 0.018, 0.075 | Increases | N/A | Vijayasankaran et al.68 | |
| CHO-S | 0, 0.1343, 0.2686 | Increases | N/A | Rouiller et al.52 | |
| CHO DG44 | 0.01, 0.02, 0.03, 0.05, 0.11 | Increases | Affected | Xu et al.53 | |
| CHO | Control Medium vs. Control Medium + 0.08 mM Iron | Decreases | N/A | Chung et al.25 | |
| CHO-GS | 0.1, 0.2, 0.4 | Increases | Increases | Gangwar et al.32 | |
| Zinc (mM) | CHO-DG44 | 0, 0.004, 0.03, 0.04, 0.07, 0.08, 0.1, 0.13, 0.15 | Decreases | N/A | Weng et al.21 |
| CHO-GS | 0.0061, 0.0138, 0.1530, 0.0306 | Increases | Decreases | Gangwar et al.22 | |
| CHO | 1X → 12X | N/A | Decreases | Luo et al.42 | |
| CHO-S | 0X, 1X, 3X | Affected | N/A | Rouiller et al.52 | |
| CHO-GS | 0.060, 0.090, 0.180 | Decreases | Decreases | Gangwar et al.32 | |
| Manganese (mM) | CHO-DG44 | 0, 0.004, 0.040 | N/A | N/A | Weng et al.21 |
| CHO-GS | 0.00091, 0, 0.00182, 0.0273 | Increases | N/A | Gangwar et al.22 | |
| CHO-S | 0, 0.0002, 0.001 | Affected | Affected | Rouiller et al.52 | |
| CHOK1SV | N/A (increased) | Decreases | Decreases | Hazeltine et al.46 | |
| Magnesium (mM) |
CHO-GS | 0.8023, 0.8147, 0.8393, 0.8517 | N/A | N/A | Gangwar et al.22 |
| Cobalt (mM) | CHO-GS | 0, 0.0017, 0.00509 | Increases | N/A | Gangwar et al.22 |
| Nickel (mM) | CHO-GS | 0, 0.017, 0.0341 | Increases | Increases | Gangwar et al.22 |
| Sodium butyrate (mM) | rCHO | 0, 0.01, 0.05, 0.2, 1, 2, 4 | Decreases | Increases | Hong et al.49 |
| Selenium (mM) | CHO-S | 0, 0.0002, 0.001 | Affected | N/A | Rouiller et al.52 |
| Biotin (mM) | CHO-GS | 0, 0.0073, 0.0094 | Decreases | Increases | Gangwar et al.22 |
| Ascorbic acid | CHO | 0, 0.568, 5.678, 17.034 | Increases | N/A | (Chumsae et al.41 |
| Surfactants (%v/v, %w/v) | CHO-DUX B11, CHO-K1 | Type: PS80, PS20, P188 | N/A | N/A | Hossler et al.69 |
| Concentration: 0.0025% − 10% | Decreases | Increases | Gangwar et al.22 | ||
| Choline (mM) | CHO-GS | 0.2414, 0.6615, 0.873, 0.912 | N/A | Affected | |
| Carboxypeptidase B (w/w) | CHO-GS, CHO-DG44 | 0, 1:100, 1:10000 | Increases | Decreases | Xu et al.70 |
| CHO | 0, 1:125 | Affected | Decreases | Kim et al.71 | |
| Methylglyoxal (mM) | CHO | 0 → 2.8 | Increases | N/A | Chumsae et al.39 |
| Folic acid (mM) | CHO-GS | 0.0062, 0.008, 0.0332, 0.0419 | N/A | N/A | Gangwar et al.22 |
| CHO/dhFr | 0, 0.2232, 0.4463 | Increases | N/A | Vijayasankaran et al.68 | |
| Dextran sulfate (g/L) | CHO-K1, DG44 | MW: 4000, 15000, 40000 | Affected | Decreases | Hyoung Park et al.72 |
| Concentration: 0.1, 0.3, 0.5, 1 | |||||
| Hydrolyzate (g/L) | CHO-K1 | 0 → 0.1 | Decreases | Increases | Zheng et al.47 |
| Taurine (mM) | CHO | 0 → 13.2 | N/A | Decreases | Liu et al.73 |
| Pantothenic acid (mM) | CHO-GS | 0.0084, 0.0138, 0.0214, 0.0559 | N/A | Decreases | Gangwar et al.22 |
| Arginine (mM) | CHO | 2 → 10 | N/A | Increases | Zhang et al.24 |
| Rutine (g/L) | CHO | 0.005 → 1 | Decreases | Increases | Hossler et al.55 |
| Rosmarinic acid (g/L) | CHO | 0 → 0.36 | Decreases | N/A | Chung et al.25 |
| Lysine (mM) | CHO | 2 → 10 | N/A | Increases | Zhang et al.24 |
| Epigallocatechin gallate (g/L) | CHO | 0.1 → 1 | Decreases | Increases | Hossler et al.55 |
| Uridine (mM) | CHO | 0 → 6 | Decreases | Increases | Niu et al.74 |
| Thiamine (mM) | CHO-GS | 0.0129, 0.0134, 0.0159, 0.0273 | N/A | Affected | Gangwar et al.22 |
| Galactose (g/L) | CHO | 0, 8, 19.50 | Increases | N/A | Quan et al.67 |
| CHO-S | 0, 1.802, 3.603 | Affected | N/A | Rouiller et al.52 | |
| β-glycerol phosphate (g/L) | CHO DG44 | 0 → 0.9 | N/A | Increases | Xu et al.70 |
| Spermine (mM) | CHO-S | 0, 0.075, 0.2 | Increases | Affected | Rouiller et al.52 |
| Asparagine (mM) | CHO-S | 0, 10, 20 | Decreases | Decreases | Rouiller et al.52 |
| Pyridoxine (mM) | CHO/dhFr | 0, 0.2, 0.4 | Increases | N/A | Vijayasankaran et al.68 |
| CHO-GS | 0, 0.02, 0.0211, 0.0287 | N/A | N/A | Gangwar et al.22 | |
| Riboflavin (mM) | CHO/dhFr | 0, 0.0133, 0.0266 | Increases | N/A | Vijayasankaran et al.68 |
| Cysteine (mM) | CHOK1SV | 1×(historical media) to 1×/1.5×(CD media) | Decreases | Decreases | Hazeltine et al.46 |
| Medium (%) | CHO | 85, 100, 115 | Decreases | N/A | Horvath et al.45 |
| CHO-DUX B11 and CHO-K1 | 1X CDFM, 2X CDFM (X) | Decreases | Increases | Hossler et al.69 | |
| CHO | BM-1, BM-2، BM-3، BM-4 | Affected | N/A | Tang et al.37 | |
| Cobalamin (mM) | CHO/dhFr | 0, 0.0177, 0.0354 | Increases | N/A | Vijayasankaran et al.68 |
| Tryptophan (mM) | CHOK1SV | 1×(historical media) to 0.7×/0.4×(CD media) | Decreases | Decreases | Hazeltine et al.46 |
aAll products are mAbs, and all media used are chemically defined.
b“→” indicates a change from one value to another; “vs.” compares two values; commas separate multiple values for the same parameter.
cEach parameter’s impact on charge variants is classified as Increase, Decrease, Affected (without a consistent trend), or N/A (no data or negligible impact reported).